Cell senescence gene database Home
Cell senescence database
General information | Literature | Expression | Regulation | Mutation | Homolog | Interaction

Basic Information

Gene ID

3479

Name

IGF1

Synonym

IGF-I|IGF1A|IGFI;insulin-like growth factor 1 (somatomedin C);IGF1;insulin-like growth factor 1 (somatomedin C)

Definition

IGF-IA|IGF-IB|MGF|insulin-like growth factor I|insulin-like growth factor IA|insulin-like growth factor IB|mechano growth factor|somatomedin-C

Position

12q23.2

Gene Type

protein-coding

Pathways and Diseases

Pathway

multiple antiapoptotic pathways from igf-1r signaling lead to bad phosphorylation;PID BioCarta;100135

Pathway

Diabetes pathways;Reactome;REACT:15380

Pathway

Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade;PANTHER;P00032

Pathway

Focal adhesion;KEGG PATHWAY;hsa04510

Pathway

Pathways in cancer;KEGG PATHWAY;hsa05200

Pathway

Hypertrophic cardiomyopathy (HCM);KEGG PATHWAY;hsa05410

Pathway

igf-1 signaling pathway;PID BioCarta;100136

Pathway

Aldosterone-regulated sodium reabsorption;KEGG PATHWAY;hsa04960

Pathway

Progesterone-mediated oocyte maturation;KEGG PATHWAY;hsa04914

Pathway

the igf-1 receptor and longevity;PID BioCarta;100115

Pathway

Prostate cancer;KEGG PATHWAY;hsa05215

Pathway

Insulin/IGF pathway-protein kinase B signaling cascade;PANTHER;P00033

Pathway

mTOR signaling pathway;KEGG PATHWAY;hsa04150

Pathway

skeletal muscle hypertrophy is regulated via akt-mtor pathway;PID BioCarta;100137

Pathway

Melanoma;KEGG PATHWAY;hsa05218

Pathway

Glioma;KEGG PATHWAY;hsa05214

Pathway

Hemostasis;Reactome;REACT:604

Pathway

regulation of bad phosphorylation;PID BioCarta;100233

Pathway

Dilated cardiomyopathy;KEGG PATHWAY;hsa05414

Pathway

Long-term depression;KEGG PATHWAY;hsa04730

Pathway

Oocyte meiosis;KEGG PATHWAY;hsa04114

Pathway

p53 signaling pathway;KEGG PATHWAY;hsa04115

Pathway

Synthesis, Secretion, and Deacylation of Ghrelin;PID Reactome;500141

Disease

Cardiovascular disease;FunDO

Disease

Growth retardation;FunDO

Disease

Subarachnoid Hemorrhage;GAD

Disease

triglycerides;GAD

Disease

DEVELOPMENTAL;GAD

Disease

IMMUNE;GAD

Disease

Alopecia;FunDO

Disease

Hyperthyroidism;FunDO

Disease

Colon cancer;FunDO

Disease

Cervical cancer;FunDO

Disease

microalbuminuria;GAD

Disease

Renal Cell cancer;FunDO

Disease

Insulin-like growth factor-3;GAD

Disease

IGFBP-3 levels;GAD

Disease

fasting insulin-related traits;GAD

Disease

Birth Weight;GAD

Disease

height;GAD

Disease

Cerebral palsy;FunDO

Disease

body height;GAD

Disease

cirrhosis, primary biliary;GAD

Disease

Osteoporosis;GAD

Disease

Osteosarcoma;FunDO

Disease

Antiphospholipid syndrome;FunDO

Disease

insulin-like growth factor;GAD

Disease

Lung cancer;FunDO

Disease

Fasting insulin-related traits;NHGRI

Disease

Liver cancer;FunDO

Disease

cardiovascular disease;GAD

Disease

prostate cancer;GAD

Disease

Cirrhosis;FunDO

Disease

insulin-like growth factor-1;GAD

Disease

bone density fractures, vertebral;GAD

Disease

Solid tumor;FunDO

Disease

lymphocyte subset counts in neonates;GAD

Disease

Fibromyalgia;FunDO

Disease

Osteoporosis;FunDO

Disease

Endocrine system disease;FunDO

Disease

Height;NHGRI

Disease

Primary tumor;FunDO

Disease

fasting glucose-related traits;GAD

Disease

small for gestational age;GAD

Disease

Hyperglycemia;FunDO

Disease

Esophagus cancer;FunDO

Disease

prostatic hyperplasia;GAD

Disease

Prostate cancer;FunDO

Disease

IGF-I levels;GAD

Disease

Polycystic kidney;FunDO

Disease

Leukemia;FunDO

Disease

METABOLIC;GAD

Disease

Growth retardation with deafness and mental retardation due to IGF1 deficiency;OMIM

Disease

Schizophrenia;FunDO

Disease

retinopathy, diabetic;GAD

Disease

Malignant pleural mesothelioma;KEGG DISEASE;H00015

Disease

colorectal cancer;GAD

Disease

estrogen metabolism;GAD

Disease

diabetes, type 2;GAD

Disease

Fibroid tumor;FunDO

Disease

Fasting glucose-related traits;NHGRI

Disease

CARDIOVASCULAR;GAD

Disease

myocardial infarct, mortality in;GAD

Disease

Late pregnancy;FunDO

Disease

Spinal cord disease;FunDO

Disease

Polycythemia;FunDO

Disease

Sickle cell disease;FunDO

Disease

REPRODUCTION;GAD

Disease

Cancers;KEGG DISEASE

Disease

postnatal growth;GAD

Disease

breast cancer;GAD

Disease

Obesity;FunDO

Disease

Advanced cancer;FunDO

Disease

Folic acid deficiency;FunDO

Disease

Protein-energy malnutrition;FunDO

Disease

Cancers of the lung and pleura;KEGG DISEASE

Disease

Hepatitis C;FunDO

Disease

IGF-I;GAD

Disease

Laron-type dwarfism;GAD

Disease

Breast cancer;FunDO

Disease

Esotropia;FunDO

Disease

Embryoma;FunDO

Disease

VISION;GAD

Disease

Pulmonary fibrosis;FunDO

Disease

Liver disease;FunDO

Disease

primary biliary cirrhosis];GAD

Disease

Alzheimer's disease;FunDO

Disease

Bone Mineral Density;GAD

Disease

Thalassemia;FunDO

Disease

CANCER;GAD

Disease

Myocardial Infarction;GAD

Disease

Weight Gain;GAD

Disease

Endometriosis;FunDO

Disease

mamographic density;GAD

Disease

Gastrointestinal stromal tumor;FunDO

Disease

Hypothyroidism;FunDO

Disease

Heart failure;FunDO

Disease

Bone disease;FunDO

Disease

Testicular dysfunction;FunDO

Disease

Acromegaly;FunDO

External Links

Links to Entrez Gene

3479

Links to all GeneRIF Items

3479

Links to iHOP

3479

Sequence Information

Nucleotide Sequence

>3479 : length: 7528
CAAATGTTCCCCCAGCTGTTTCCTGTCTACAGTGTCTGTGTTTTGTAGATAAATGTGAGG
ATTTTCTCTAAATCCCTCTTCTGTTTGCTAAATCTCACTGTCACTGCTAAATTCAGAGCA
GATAGAGCCTGCGCAATGGAATAAAGTCCTCAAAATTGAAATGTGACATTGCTCTCAACA
TCTCCCATCTCTCTGGATTTCTTTTTGCTTCATTATTCCTGCTAACCAATTCATTTTCAG
ACTTTGTACTTCAGAAGCAATGGGAAAAATCAGCAGTCTTCCAACCCAATTATTTAAGTG
CTGCTTTTGTGATTTCTTGAAGGTGAAGATGCACACCATGTCCTCCTCGCATCTCTTCTA
CCTGGCGCTGTGCCTGCTCACCTTCACCAGCTCTGCCACGGCTGGACCGGAGACGCTCTG
CGGGGCTGAGCTGGTGGATGCTCTTCAGTTCGTGTGTGGAGACAGGGGCTTTTATTTCAA
CAAGCCCACAGGGTATGGCTCCAGCAGTCGGAGGGCGCCTCAGACAGGCATCGTGGATGA
GTGCTGCTTCCGGAGCTGTGATCTAAGGAGGCTGGAGATGTATTGCGCACCCCTCAAGCC
TGCCAAGTCAGCTCGCTCTGTCCGTGCCCAGCGCCACACCGACATGCCCAAGACCCAGAA
GTATCAGCCCCCATCTACCAACAAGAACACGAAGTCTCAGAGAAGGAAAGGTTGGCCAAA
GACACATCCAGGAGGGGAACAGAAGGAGGGGACAGAAGCAAGTCTGCAGATCAGAGGAAA
GAAGAAAGAGCAGAGGAGGGAGATTGGAAGTAGAAATGCTGAATGCAGAGGCAAAAAAGG
AAAATGAAGGACAGGAGGATTAAACAGACAGAGGCAAGGATGATGAGAGAGGAGCAGACA
GCAAGAATGAAAAGCAGAAAATACAATAGAGGAAATGAAGAAAAGTAGGCCTGCTGGAGC
TAGATGATGATGTGATGGAAATAGAAGTAACCTTTTAGAGAATCTCGCTAAGAAACATGG
AGAAAACGGAAAAGAAAAATGTAATGCCCTAGAAAGCGCAAAGAAAGACAGTGGCAAAAA
TGAAAAAAAAAAATAAAAATTATAAAAGAGGCAAAAAAAGACACACTATTCTCTGCCTCT
AAAACACAATTAAATAAAAGAATTTAAATAAAAATTAAGGCTTCTATATGCATTTTTAAA
TTTTGTATGAATCTGTTATGGAAGAATTGCCTATGTCAATATATGTTCAGAGTTAAATAT
TAGCCCCAAATGCTCAGCAAGACTGAATTGTGTCATAGAAGTTCCCAGATTCCCTTTTCC
CGCAATGTCATTGGAGGCTGCATTTCTTAGTCAAGTCCAGGGTTTAGGCCAAAGGGCATC
CGGTATTGCCTAAAACCCTGTGAGGTCTGTGAGGTAACTTTTGAGAAGAGGTCACTGCAC
TCTTCATCTTTTTTGCACTTTGGAATCAGATATAAAAGATGTATAAGTTTGCTAGGGCTG
CCATAACAAAGTATCATAGGCTAGGTAGTTTAAACCACAGAAATTGATTTTTTCATAGTT
CTGGGAGTTGAAAGTCCAAAATCAAAGTATCAGCCCTTGCAAGGGCCTTAGAGAAGGCTC
TGTCATGGGCTCCTCCCCTCGGCTTGTAGGTGGCCTCCTTCTTCTCCCCCTGTGTCTTCA
CTTCATCTTCCCTCCATACATATCTCTGTGTCTAAACATCCTCTGTGTGAAACAACACCA
GCCAGGTTGGATTTGGGCCCACCCCACTGACCTCATTTTAACTTAATTATCTCTGTAAAG
ACTCTGTCTCCAAATACAGTCATATTTTGACGTACTGGGAGTTAGGGCTTCAACACATGA
ATTTGGACACAATTCAGCCAGTGACAGAAGACTTCTGATCTCTGATGATAACCACTGCAT
TTTGATTACAGCTCCTAGAAAACACTCCCCTCCACCACCCCACCACAGATCTATTTTTAT
ATCTGAAACCCTGAGTTTCTGCTCCATGAGAACCCCAGGAACATACTATGTTAGATCTGG
AAGAAGCCTCAGAAATCCCCTTATTTTGAAGACTAGGACACTGAGATCCAGAAGTGGGTA
AAGATGTGCTTGGGTTCTAAGCTGCTCTTCTTTTGGCCAGGAGACAACAGCACATAATCA
AAGTGGGTCAACTAAGAAAGAATTCCAGAAGGAAAAGAGAGGGCAGAAATGAAGGGAGAG
AATGAGAGCAAAAGTGCTGGATTTCCCTGAGGGTGAAGAAAAGTTAAATAGAATCACAGA
ATTCAGATTTTAGAGATCTTCTCCTTCAGATCCCTTGGTTTAATCAGTAGGATTGGGGTC
TTCATAGATAATAAAGCAAAAACTCTCGCCATCCTCCAAGTTGTGAATTAGAAGAGCTGA
GAAAGGGTACAAGACGGAAGTTCTCTACCAAACAAATGGTGACATTTTGGGGTAAGAATA
TGACTAACCCAGAAGTGAAGCATTTCATCCAAGTAGTCTATTTTGAAGATGTCATGGTAT
AAAGGAACCTCCTTTCTGCCTGGTCCTCCATGCCTCTGCCATGCTTTTTACTCCAGGATC
ACCCTTTCTAGTGGTTCACTGAAAACCCAGGATTACTTAAATATGATGGACATGTTCACG
GCTCAATCCAGGAGGAAAAGGTCGAACTGAAAGCATGCCAAAGCCCCACATGGGAGCCAA
GCCACTGCTGCTGTGGTTGCAAAGTGGATCCTGGCTTATCAGAGCAGAGAGAAGCCAGGC
TCGTGCCTTAGCCCAAGTGGCCAGTCACCTTATTCAGGAGATACTAAGTTCTCCAGCTAA
GACATCCATGCTTTGGGACCAGCTGCAGACAGAAGCCAATTCCTACTACAACCATCACCT
TAGAGTAGCATATAGACACAGATGGCTCTTCAAAGGACCACAGTTCCATGGAATAACTAA
GAATTCATGTCCTGTGGAAAGGAAGTACATTTGAAGAACGCAAGTAGAGGGAGTGCAGGA
AACAAGAACTACAGGATGTAGGAAGACCCTCCTGAGGAGTGAAGAGTGACATGCCACCGC
AGGATCCTTTGCTCTGCACGAGTTACCTGTTAAACTTTGGAACACCTACCAAAAAATAAG
TTTGATAACATTTAAAAGATGGGCGTTTCCCCCAATGAAATACACAAGTAAACATTCCAA
CATTGTCTTTAGGAGTGATTTGCACCTTGCAAAAATGGTCCTGGAGTTGGTAGATTGCTG
TTGATCTTTTATCAATAATGTTCTATAGAAAAGAAAAAAAAAATATATATATATATATAT
CTTAGTCCCTGCCTCTCAAGAGCCACAAATGCATGGGTGTTGTATAGATCCAGTTGCACT
AAATTCCTCTCTGAATCTTGGCTGCTGGAGCCATTCATTCAGCAACCTTGTCTAAGTGGT
TTATGAATTGTTTCCTTATTTGCACTTCTTTCTACACAACTCGGGCTGTTTGTTTTACAG
TGTCTGATAATCTTGTTAGTCTATACCCACCACCTCCCTTCATAACCTTTATATTTGCCG
AATTTGGCCTCCTCAAAAGCAGCAGCAAGTCGTCAAGAAGCACACCAATTCTAACCCACA
AGATTCCATCTGTGGCATTTGTACCAAATATAAGTTGGATGCATTTTATTTTAGACACAA
AGCTTTATTTTTCCACATCATGCTTACAAAAAAGAATAATGCAAATAGTTGCAACTTTGA
GGCCAATCATTTTTAGGCATATGTTTTAAACATAGAAAGTTTCTTCAACTCAAAAGAGTT
CCTTCAAATGATGAGTTAATGTGCAACCTAATTAGTAACTTTCCTCTTTTTATTTTTTCC
ATATAGAGCACTATGTAAATTTAGCATATCAATTATACAGGATATATCAAACAGTATGTA
AAACTCTGTTTTTTAGTATAATGGTGCTATTTTGTAGTTTGTTATATGAAAGAGTCTGGC
CAAAACGGTAATACGTGAAAGCAAAACAATAGGGGAAGCCTGGAGCCAAAGATGACACAA
GGGGAAGGGTACTGAAAACACCATCCATTTGGGAAAGAAGGCAAAGTCCCCCCAGTTATG
CCTTCCAAGAGGAACTTCAGACACAAAAGTCCACTGATGCAAATTGGACTGGCGAGTCCA
GAGAGGAAACTGTGGAATGGAAAAAGCAGAAGGCTAGGAATTTTAGCAGTCCTGGTTTCT
TTTTCTCATGGAAGAAATGAACATCTGCCAGCTGTGTCATGGACTCACCACTGTGTGACC
TTGGGCAAGTCACTTCACCTCTCTGTGCCTCAGTTTCCTCATCTGCAAAATGGGGGCAAT
ATGTCATCTACCTACCTCAAAGGGGTGGTATAAGGTTTAAAAAGATAAAGATTCAGATTT
TTTTTACCCTGGGTTGCTGTAAGGGTGCAACATCAGGGCGCTTGAGTTGCTGAGATGCAA
GGAATTCTATAAATAACCCATTCATAGCATAGCTAGAGATTGGTGAATTGAATGCTCCTG
ACATCTCAGTTCTTGTCAGTGAAGCTATCCAAATAACTGGCCAACTAGTTGTTAAAAGCT
AACAGCTCAATCTCTTAAAACACTTTTCAAAATATGTGGGAAGCATTTGATTTTCAATTT
GATTTTGAATTCTGCATTTGGTTTTATGAATACAAAGATAAGTGAAAAGAGAGAAAGGAA
AAGAAAAAGGAGAAAAACAAAGAGATTTCTACCAGTGAAAGGGGAATTAATTACTCTTTG
TTAGCACTCACTGACTCTTCTATGCAGTTACTACATATCTAGTAAAACCTCGTTTAATAC
TATAAATAATATTCTATTCATTTTGAAAAACACAATGATTCCTTCTTTTCTAGGCAATAT
AAGGAAAGTGATCCAAAATTTGAAATATTAAAATAATATCTAATAAAAAGTCACAAAGTT
ATCTTCTTTAACAAACTTTACTCTTATTCTTAGCTGTATATACATTTTTTTAAAAGTTTG
TTAAAATATGCTTGACTAGAGTTTCCAGTTGAAAGGCAAAAACTTCCATCACAACAAGAA
ATTTCCCATGCCTGCTCAGAAGGGTAGCCCCTAGCTCTCTGTGAATGTGTTTTATCCATT
CAACTGAAAATTGGTATCAAGAAAGTCCACTGGTTAGTGTACTAGTCCATCATAGCCTAG
AAAATGATCCCTATCTGCAGATCAAGATTTTCTCATTAGAACAATGAATTATCCAGCATT
CAGATCTTTCTAGTCACCTTAGAACTTTTTGGTTAAAAGTACCCAGGCTTGATTATTTCA
TGCAAATTCTATATTTTACATTCTTGGAAAGTCTATATGAAAAACAAAAATAACATCTTC
AGTTTTTCTCCCACTGGGTCACCTCAAGGATCAGAGGCCAGGAAAAAAAAAAAAAAGACT
CCCTGGATCTCTGAATATATGCAAAAAGAAGGCCCCATTTAGTGGAGCCAGCAATCCTGT
TCAGTCAACAAGTATTTTAACTCTCAGTCCAACATTATTTGAATTGAGCACCTCAAGCAT
GCTTAGCAATGTTCTAATCACTATGGACAGATGTAAAAGAAACTATACATCATTTTTGCC
CTCTGCCTGTTTTCCAGACATACAGGTTCTGTGGAATAAGATACTGGACTCCTCTTCCCA
AGATGGCACTTCTTTTTATTTCTTGTCCCCAGTGTGTACCTTTTAAAATTATTCCCTCTC
AACAAAACTTTATAGGCAGTCTTCTGCAGACTTAACGTGTTTTCTGTCATAGTTAGATGT
GATAATTCTAAGAGTGTCTATGACTTATTTCCTTCACTTAATTCTATCCACAGTCAAAAA
TCCCCCAAGGAGGAAAGCTGAAAGATGCACTGCCATATTATCTTTCTTAACTTTTTCCAA
CACATAATCCTCTCCAACTGGATTATAAATAAATTGAAAATAACTCATTATACCAATTCA
CTATTTTATTTTTTAATGAATTAAAACTAGAAAACAAATTGATGCAAACCCTGGAAGTCA
GTTGATTACTATATACTACAGCAGAATGACTCAGATTTCATAGAAAGGAGCAACCAAAAT
GTCACAACCCAAAACTTTACAAGCTTTGCTTCAGAATTAGATTGCTTTATAATTCTTGAA
TGAGGCAATTTCAAGATATTTGTAAAAGAACAGTAAACATTGGTAAGAATGAGCTTTCAA
CTCATAGGCTTATTTCCAATTTAATTGACCATACTGGATACTTAGGTCAAATTTCTGTTC
TCTCTTCCCCAAATAATATTAAAGTATTATTTGAACTTTTTAAGATGAGGCAGTTCCCCT
GAAAAAGTTAATGCAGCTCTCCATCAGAATCCACTCTTCTAGGGATATGAAAATCTCTTA
ACACCCACCCTACATACACAGACACACACACACACACACACACACACACACACACACACA
TTCACCCTAAGGATCCAATGGAATACTGAAAAGAAATCACTTCCTTGAAAATTTTATTAA
AAAACAAACAAACAAACAAAAAGCCTGTCCACCCTTGAGAATCCTTCCTCTCCTTGGAAC
GTCAATGTTTGTGTAGATGAAACCATCTCATGCTCTGTGGCTCCAGGGTTTCTGTTACTA
TTTTATGCACTTGGGAGAAGGCTTAGAATAAAAGATGTAGCACATTTTGCTTTCCCATTT
ATTGTTTGGCCAGCTATGCCAATGTGGTGCTATTGTTTCTTTAAGAAAGTACTTGACTAA
AAAAAAAAGAAAAAAAGAAAAAAAAGAAAGCATAGACATATTTTTTTAAAGTATAAAAAC
AACAATTCTATAGATAGATGGCTTAATAAAATAGCATTAGGTCTATCTAGCCACCACCAC
CTTTCAACTTTTTATCACTCACAAGTAGTGTACTGTTCACCAAATTGTGAATTTGGGGGT
GCAGGGGCAGGAGTTGGAAATTTTTTAAAGTTAGAAGGCTCCATTGTTTTGTTGGCTCTC
AAACTTAGCAAAATTAGCAATATATTATCCAATCTTCTGAACTTGATCAAGAGCATGGAG
AATAAACGCGGGAAAAAAGATCTTATAGGCAAATAGAAGAATTTAAAAGATAAGTAAGTT
CCTTATTGATTTTTGTGCACTCTGCTCTAAAACAGATATTCAGCAAGTGGAGAAAATAAG
AACAAAGAGAAAAAATACATAGATTTACCTGCAAAAAATAGCTTCTGCCAAATCCCCCTT
GGGTATTCTTTGGCATTTACTGGTTTATAGAAGACATTCTCCCTTCACCCAGACATCTCA
AAGAGCAGTAGCTCTCATGAAAAGCAATCACTGATCTCATTTGGGAAATGTTGGAAAGTA
TTTCCTTATGAGATGGGGGTTATCTACTGATAAAGAAAGAATTTATGAGAAATTGTTGAA
AGAGATGGCTAACAATCTGTGAAGATTTTTTGTTTCTTGTTTTTGTTTTTTTTTTTTTTT
TACTTTATACAGTCTTTATGAATTTCTTAATGTTCAAAATGACTTGGTTCTTTTCTTCTT
TTTTTATATCAGAATGAGGAATAATAAG

Protein Sequence

>3479 : length: 195
MGKISSLPTQLFKCCFCDFLKVKMHTMSSSHLFYLALCLLTFTSSATAGPETLCGAELVD
ALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSARS
VRAQRHTDMPKTQKYQPPSTNKNTKSQRRKGWPKTHPGGEQKEGTEASLQIRGKKKEQRR
EIGSRNAECRGKKGK



')